Month: February 2024

THE NEW STUDY ON “THE JOURNAL OF CLINICAL MEDICINE”

THE NEW STUDY ON “THE JOURNAL OF CLINICAL MEDICINE”

On 11 February 2024 the international, peer-reviewed online journal, The Journal of Clinical Medicine published a new study on a new treatment option for hyper- and hypopigmentation in a subject with Fitzpatrick skin phototype VI. In the article you will read how it...

BIODERMOGENESI® AT DUBAI DERMA 2024

BIODERMOGENESI® AT DUBAI DERMA 2024

Only a few days left to the 23rd edition of Dubai Derma 2024!   We are excited to announce that Biodermogenesi will be participating the congress held in Dubai World Trade Centre on 5-7 March 2024.   Come meet us at the stand 8F16. We look forward to meeting...

Pledge Times: “Ukraine, Italian project to treat war wounds begins”

Pledge Times: “Ukraine, Italian project to treat war wounds begins”

Yesterday, Pledge Times published an article about the RigeneraDerma's humanitarian project -Mission to Kiev- which was launched on Wednesday Feb. 21st in Rome, Italy.   Mission to Kiev is a humanitarian mission born from the experience in scar therapy developed by...

info

BIODERMOGENESI® is a registered trademark or property of EXPO ITALIA s.r.l.

Florence (ITALY)

Contacts

E-mail infouk@biodermogenesi.com

VAT 04697040485

Follow Us
FacebookFacebookYoutube